SCHEMBL6630356

SCHEMBL6630356

NC(=O)c1ccccc1Sc1ncc(Cl)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.50
PKM P14618 1/20 0.36
CASP1 P29466 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
TRPA1 O75762 1/20 0.35
KMT2A Q03164 2/20 0.34
ATM Q13315 1/20 0.34
PARP1 P09874 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7706549 0.81 SIRT1 (0.48) SIRT1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL6633089 0.81 SIRT1 (0.48) SIRT1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL6632529 0.80 SIRT1 (0.47) SIRT1KDM4EMAPTPARP1GLA
SCHEMBL3077375 0.74 SIRT1 (0.77) SIRT1PKMKDM4EHPGDALDH1A1
SCHEMBL6632649 0.74 SIRT1 (0.53) SIRT1PKMKDM4EHPGDALDH1A1
SCHEMBL6630850 0.72 SIRT1 (0.59) SIRT1PKMSMN1; SMN2KDM4EHPGD
SCHEMBL6647601 0.71 SIRT1 (0.53) SIRT1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL11334883 0.69 SIRT1 (0.74) SIRT1KDM4EALDH1A1MAPTKMT2A
SCHEMBL6633917 0.68 SIRT1 (0.53) SIRT1KDM4EHPGDALDH1A1HSD17B10
SCHEMBL1030659 0.68 SIRT1 (1.00) SIRT1SMN1; SMN2KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1480977-A2 SUBSTITUTED ARYL COMPOUNDS FOR TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-12-01 EP disclosed
WO-2003070728-A2 AZABICYCLO-SUBSTITUTED BENZOYLAMIDES AND THIOAMIDES FOR TREATMENT OF CNS-RELATED DISORDERS PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed